T. Rowe Price Health Sciences Fund (PRHSX)
The fund will normally invest at least 80% of its net assets (including any borrowings for investment purposes) in the common stocks of companies engaged in the research, development, production, or distribution of products or services related to health care, medicine, or the life sciences (collectively termed "health sciences"). While the fund can invest in companies of any size, the majority of fund assets are expected to be invested in large- and mid-capitalization companies.
Fund Info
US7414801073
741480107
Dec 29, 1995
$2,500
Large-Cap
Growth
Expense Ratio
PRHSX has an expense ratio of 0.80%, placing it in the medium range.
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in T. Rowe Price Health Sciences Fund, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
T. Rowe Price Health Sciences Fund (PRHSX) returned -4.69% year-to-date (YTD) and -18.31% over the past 12 months. Over the past 10 years, PRHSX returned -0.28% annually, underperforming the S&P 500 benchmark at 10.31%.
PRHSX
-4.69%
3.94%
-22.25%
-18.31%
-1.62%
-0.28%
^GSPC (Benchmark)
-4.26%
11.24%
-5.02%
8.55%
14.02%
10.31%
Monthly Returns
The table below presents the monthly returns of PRHSX, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 6.20% | -1.84% | -4.11% | -0.09% | -4.57% | -4.69% | |||||||
| 2024 | 2.05% | 4.06% | 1.66% | -4.97% | 2.31% | 2.85% | 2.68% | 5.19% | -1.95% | -5.00% | 1.49% | -17.90% | -9.51% |
| 2023 | 0.58% | -4.69% | 1.92% | 3.57% | -2.94% | 2.90% | -0.14% | -1.51% | -3.85% | -3.89% | 5.56% | 0.94% | -2.14% |
| 2022 | -12.38% | -0.39% | 4.75% | -8.57% | -0.90% | -0.56% | 5.58% | -3.09% | -4.25% | 7.68% | 4.16% | -4.64% | -13.70% |
| 2021 | 2.35% | -1.82% | -0.77% | 4.95% | -0.92% | 5.61% | 2.02% | 4.16% | -4.66% | 4.21% | -4.90% | -4.24% | 5.29% |
| 2020 | -2.69% | -4.35% | -6.98% | 13.91% | 7.60% | 0.75% | 3.29% | 1.79% | 1.63% | -1.10% | 10.03% | -2.35% | 21.39% |
| 2019 | 11.60% | 2.71% | 0.77% | -4.37% | -2.08% | 8.64% | -1.28% | -2.88% | -3.68% | 6.57% | 8.54% | -3.13% | 21.59% |
| 2018 | 8.51% | -4.85% | -1.84% | 0.27% | 4.39% | 1.57% | 3.76% | 6.23% | 1.23% | -9.48% | 4.43% | -16.19% | -4.75% |
| 2017 | 4.91% | 6.99% | -0.87% | 2.31% | -0.68% | 5.75% | 1.59% | 2.29% | 1.32% | -0.71% | 2.75% | -7.26% | 19.08% |
| 2016 | -13.61% | -0.54% | 2.23% | 1.65% | 3.50% | -0.93% | 4.74% | -3.09% | 1.33% | -7.74% | 5.15% | -6.09% | -14.20% |
| 2015 | 4.31% | 6.37% | 2.74% | -2.79% | 8.16% | 0.33% | 2.73% | -7.05% | -8.43% | 4.27% | 0.97% | -8.52% | 1.28% |
| 2014 | 5.74% | 6.40% | -5.80% | -3.05% | 4.13% | 3.41% | 0.88% | 7.04% | -0.68% | 6.50% | 3.57% | -10.13% | 17.63% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of PRHSX is 1, meaning it’s performing worse than 99% of other mutual funds on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for T. Rowe Price Health Sciences Fund (PRHSX) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
T. Rowe Price Health Sciences Fund provided a 13.52% dividend yield over the last twelve months, with an annual payout of $10.25 per share. The fund has been increasing its distributions for 2 consecutive years.
| Period | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend | $10.25 | $10.25 | $4.58 | $1.59 | $7.76 | $7.08 | $5.03 | $4.40 | $5.23 | $2.69 | $7.81 | $8.10 |
Dividend yield | 13.52% | 12.89% | 5.21% | 1.77% | 7.46% | 7.16% | 6.18% | 6.57% | 7.43% | 4.55% | 11.34% | 11.91% |
Monthly Dividends
The table displays the monthly dividend distributions for T. Rowe Price Health Sciences Fund. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||
| 2024 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $10.25 | $10.25 |
| 2023 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $4.58 | $4.58 |
| 2022 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $1.59 | $1.59 |
| 2021 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $7.76 | $7.76 |
| 2020 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $7.08 | $7.08 |
| 2019 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $5.03 | $5.03 |
| 2018 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $4.40 | $4.40 |
| 2017 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $5.23 | $5.23 |
| 2016 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $2.69 | $2.69 |
| 2015 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $7.81 | $7.81 |
| 2014 | $8.10 | $8.10 |
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Worst Drawdowns
The table below displays the maximum drawdowns of the T. Rowe Price Health Sciences Fund. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the T. Rowe Price Health Sciences Fund was 47.79%, occurring on Jul 23, 2002. Recovery took 787 trading sessions.
The current T. Rowe Price Health Sciences Fund drawdown is 35.29%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -47.79% | Nov 3, 2000 | 425 | Jul 23, 2002 | 787 | Sep 7, 2005 | 1212 |
| -47.78% | Dec 11, 2007 | 239 | Nov 20, 2008 | 541 | Jan 14, 2011 | 780 |
| -38.58% | Sep 3, 2021 | 902 | Apr 8, 2025 | — | — | — |
| -34.37% | Aug 6, 2015 | 131 | Feb 11, 2016 | 1080 | May 28, 2020 | 1211 |
| -29.72% | Mar 6, 2000 | 30 | Apr 14, 2000 | 58 | Jul 11, 2000 | 88 |
Volatility
Volatility Chart
The current T. Rowe Price Health Sciences Fund volatility is 9.35%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.